Cyproheptadine HCl

CAS No. 969-33-5

Cyproheptadine HCl( —— )

Catalog No. M19289 CAS No. 969-33-5

Cyproheptadine HCl is a hydrochloride salt form of cyproheptadine which is a histamine receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 45 In Stock
100MG 54 In Stock
500MG 65 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cyproheptadine HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyproheptadine HCl is a hydrochloride salt form of cyproheptadine which is a histamine receptor antagonist.
  • Description
    Cyproheptadine HCl is a hydrochloride salt form of cyproheptadine which is a histamine receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    Animal Model:C57BL/6 mice (8-10 weeks old)Dosage:1 mg/kg Administration:Intraperitoneal injection, daily, for 5 days Result:Prolonged occlusion times and tail bleeding times in mice.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    HT
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    969-33-5
  • Formula Weight
    323.86
  • Molecular Formula
    C21H21N·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL 154.39 mM; H2O : < 0.1 mg/mL
  • SMILES
    Cl.CN1CCC(CC1)=C1C2=C(C=CC=C2)C=CC2=C1C=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GSK205

    GSK205 is a selective TRPV4 antagonist that blocks Ca(2+) signaling and may be used to reduce inflammation and pain.

  • Tiapamil hydrochlori...

    Tiapamil hydrochloride (Ro 11-1781 hydrochloride) is a calcium channel blocker with antihypertensive activity and may be used in the study of angina and cardiovascular disease.

  • Vatanidipine

    Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.